Homer1/mGluR5 Activity Moderates Vulnerability to Chronic Social Stress

Neuropsychopharmacology

Volumn 40, Issue , 2015, Pages 1222-1233

  Wagner, Klaus V ^a   Hartmann, Jakob ^a   Labermaier, Christiana ^a   Häusl, Alexander S ^a   Zhao, Gengjing ^a   Harbich, Daniela ^a   Schmid, Bianca ^a   Wang, Xiao Dong ^b   Santarelli, Sara ^a   Kohl, Christine ^a   Gassen, Nils C ^a   Matosin, Natalie ^c,d   Schieven, Marcel ^a   Webhofer, Christian ^a   Turck, Christoph W ^a   Lindemann, Lothar ^e   Jaschke, Georg ^e   Wettstein, Joseph G ^e   Rein, Theo ^a   Müller, Marianne B ^a   Schmidt, Mathias V ^a   more..

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c UNIVERSITY OF WOLLONGONG   (Australia)

^d SCHIZOPHRENIA RESEARCH INSTITUTE   (Australia)

^e F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

2CHLORO4 [[2,5 DIMETHYL 1 [4 (TRIFLUOROMETHOXY)PHENYL] 1H IMIDAZOL 4YL]ETHYNYL]PYRIDINE; ANTIDEPRESSANT AGENT; MESSENGER RNA; METABOTROPIC RECEPTOR 5; METABOTROPIC RECEPTOR ANTAGONIST; PROTEIN HOMER 1A; PROTEIN HOMER 1B; PROTEIN HOMER 1C; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG; 2 CHLORO 4 [[2,5 DIMETHYL 1 [4 (TRIFLUOROMETHOXY)PHENYL] 1H IMIDAZOL 4 YL]ETHYNY]PYRIDINE; METABOTROPIC RECEPTOR AGONIST; PROTEIN HOMER 1; 2-CHLORO-4-((2,5-DIMETHYL-1-(4-(TRIFLUOROMETHOXY)PHENYL)-1H-IMIDAZOL-4-YL)ETHYNYL)PYRIDINE; AMINO ACID RECEPTOR BLOCKING AGENT; CARRIER PROTEIN; GRM5 PROTEIN, MOUSE; IMIDAZOLE DERIVATIVE; ISOPROTEIN; PROTEIN HOMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC DRUG ADMINISTRATION; CHRONIC STRESS; CONTROLLED STUDY; DENTATE GYRUS; DEPRESSION; DORSAL HIPPOCAMPUS; GENE DELETION; GENE OVEREXPRESSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMEDIATE EARLY GENE; IN SITU HYBRIDIZATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOCIAL STRESS; UPREGULATION; COPING BEHAVIOR; DRUG MECHANISM; FORCED SWIM TEST; HIPPOCAMPUS; LOCOMOTION; LONG TERM CARE; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR OCCUPANCY; REGULATORY MECHANISM; RNA PROCESSING; SOCIAL BEHAVIOR; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN; C57BL MOUSE; CHRONIC DISEASE; DISEASE MODEL; DRUG EFFECTS; GENETICS; INVERSE AGONISM; KNOCKOUT MOUSE; MENTAL STRESS; METABOLISM; SOCIAL DOMINANCE;

ANIMALS; BRAIN; CARRIER PROTEINS; CHRONIC DISEASE; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; DOMINANCE-SUBORDINATION; DRUG INVERSE AGONISM; EXCITATORY AMINO ACID ANTAGONISTS; IMIDAZOLES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEIN ISOFORMS; PYRIDINES; RECEPTOR, METABOTROPIC GLUTAMATE 5; RESILIENCE, PSYCHOLOGICAL; RNA, MESSENGER; STRESS, PSYCHOLOGICAL;

EID: 84925497955     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2014.308     Document Type: Article

References (64)

1. Anderson JJ, Bradbury MJ, Giracello DR, Chapman DF, Holtz G, Roppe J et al (2003). In vivo receptor occupancy of mGlu5 receptor antagonists using the novel radioligand [3H]3-methoxy-5-(pyridin-2-ylethynyl)pyridine). Eur J Pharmacol 473: 35-40.
2. Ango F, Prézeau L, Muller T, Tu JC, Xiao B, Worley PF et al (2001). Agonist-independent activation of metabotropic glutamate receptors by the intracellular protein Homer. Nature 411:962-965.
3. Ary AW, Aguilar VR, Szumlinski KK, Kippin TE (2007). Prenatal stress alters limbo-corticostriatal Homer protein expression. Synapse 61: 938-941.
4. Ary AW, Lominac KD, Wroten MG, Williams AR, Campbell RR, Ben-Shahar O et al (2013). Imbalances in prefrontal cortex CC-Homer1 versus CC-Homer2 expression promote cocaine preference. J Neurosci 33: 8101-8113.
5. Bertaso F, Roussignol G, Worley P, Bockaert J, Fagni L, Ango F (2010). Homer1a-dependent crosstalk between NMDA and metabotropic glutamate receptors in mouse neurons. PLoS One 5: e9755.
6. Berton O, McClung CA, Dileone RJ, Krishnan V, Renthal W, Russo SJ et al (2006). Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311 : 864-868.
7. Brakeman PR, Lanahan AA, O'Brien R, Roche K, Barnes CA, Huganir RL et al (1997). Homer: a protein that selectively binds metabotropic glutamate receptors. Nature 386: 284-288.
8. Busse CS, Brodkin J, Tattersall D, Anderson JJ, Warren N, Tehrani L et al (2004). The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]- pyridine (MTEP) in rodent models of anxiety. Neuropsychopharmacology 29: 1971-1979.
9. Celikel T, Marx V, Freudenberg F, Zivkovic A, Resnik E, Hasan MT et al (2007). Select overexpression of homer1a in dorsal hippocampus impairs spatial working memory. Front Neurosci 1: 97-110.
10. Chrousos GP (2009). Stress and disorders of the stress system. Nat Rev Endocrinol 5: 374-381.
11. Connolly KR, Thase ME (2011). If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies. Drugs 71: 43-64.
12. Cryan JF, Holmes A (2005). The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discov 4: 775-790.
13. de Bartolomeis A, Iasevoli F (2003). The Homer family and the signal transduction system at glutamatergic postsynaptic density: potential role in behavior and pharmacotherapy. Psychopharmacol Bull 37: 51-83.
14. de Kloet ER, Joëls M, Holsboer F (2005). Stress and the brain: from adaptation to disease. Nat Rev Neurosci 6: 463-475.
15. Grinevich V, Jezova D, Gambaryan S, Illarionova A, Kolleker A, Seeburg PH et al (2011). Hypertrophy and altered activity of the adrenal cortex in Homer 1 knockout mice. Horm Metab Res 43: 551-556.
16. Hartmann J, Wagner KV, Liebl C, Scharf SH, Wang XD, Wolf M et al (2012). The involvement of FK506-binding protein 51 (FKBP5) in the behavioral and neuroendocrine effects of chronic social defeat stress. Neuropharmacology 62: 332-339.
17. Hayashi MK, Tang C, Verpelli C, Narayanan R, Stearns MH, Xu RM et al (2009). The postsynaptic density proteins Homer and Shank form a polymeric network structure. Cell 137: 159-171.
18. Hong Q, Wang YP, Zhang M, Pan XQ, Guo M, Li F et al (2011). Homer expression in the hippocampus of an animal model of attention-deficit/hyperactivity disorder. Mol Med Rep 4: 705-712.
19. Hong Q, Zhang M, Pan XQ, Guo M, Li F, Tong ML et al (2009). Prefrontal cortex Homer expression in an animal model of attention-deficit/hyperactivity disorder. J Neurol Sci 287: 205-211.
20. Jaubert PJ, Golub MS, Lo YY, Germann SL, Dehoff MH, Worley PF et al (2007). Complex, multimodal behavioral profile of the Homer1 knockout mouse. Genes Brain Behav 6: 141-154.
21. Joëls M, Baram TZ (2009). The neuro-symphony of stress. Nat Rev Neurosci 10: 459-466.
22. Kammermeier PJ (2008). Endogenous homer proteins regulate metabotropic glutamate receptor signaling in neurons. J Neurosci 28: 8560-8567.
23. Kammermeier PJ, Worley PF (2007). Homer 1a uncouples metabotropic glutamate receptor 5 from postsynaptic effectors. Proc Natl Acad Sci USA 104: 6055-6060.
24. Kato A, Ozawa F, Saitoh Y, Hirai K, Inokuchi K (1997). vesl, a gene encoding VASP/Ena family related protein, is upregulated during seizure, long-term potentiation and synaptogenesis. FEBS Lett 412: 183-189.
25. Kavalali ET, Monteggia LM (2012). Synaptic mechanisms underlying rapid antidepressant action of ketamine. Am J Psychiatry 169: 1150-1156.
26. Kendell SF, Krystal JH, Sanacora G (2005). GABA and glutamate systems as therapeutic targets in depression and mood disorders. Expert Opin Ther Targets 9: 153-168.
27. Krystal JH, Mathew SJ, D'Souza DC, Garakani A, Gunduz-Bruce H, Charney DS (2010). Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists. CNS Drugs 24: 669-693.
28. Krystal JH, Sanacora G, Duman RS (2013). Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond. Biol Psychiatry 73: 1133-1141.
29. Lindemann L, Jaeschke G, Michalon A, Vieira E, Honer M, Spooren W et al (2011). CTEP: a novel, potent, long-acting, and orally bioavailable metabotropic glutamate receptor 5 inhibitor. J Pharmacol Exp Ther 339: 474-486.
30. Lominac KD, Oleson EB, Pava M, Klugmann M, Schwarz MK, Seeburg PH et al (2005). Distinct roles for different Homer1 isoforms in behaviors and associated prefrontal cortex function. J Neurosci 25: 11586-11594.
31. Mahan AL, Mou L, Shah N, Hu JH, Worley PF, Ressler KJ (2012). Epigenetic modulation of Homer1a transcription regulation in amygdala and hippocampus with pavlovian fear conditioning. J Neurosci 32: 4651-4659.
32. Malkesman O, Scattoni ML, Paredes D, Tragon T, Pearson B, Shaltiel G et al (2010). The female urine sniffing test: a novel approach for assessing reward-seeking behavior in rodents. Biol Psychiatry 67: 864-871.
33. Mathews DC, Henter ID, Zarate CA (2012). Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date. Drugs 72: 1313-1333.
34. McEwen BS (2004). Protection and damage from acute and chronic stress: allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders. Ann NY Acad Sci 1032: 1-7.
35. Michalon A, Sidorov M, Ballard TM, Ozmen L, Spooren W, Wettstein JG et al (2012). Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice. Neuron 74 : 49-56.
36. Mutlu O, Gumuslu E, Ulak G, Celikyurt IK, Kokturk S, Kir HM et al (2012). Effects of fluoxetine, tianeptine and olanzapine on unpredictable chronic mild stress-induced depression-like behavior in mice. Life Sci 91: 1252-1262.
37. Nestler EJ, Hyman SE (2010). Animal models of neuropsychiatric disorders. Nat Neurosci 13: 1161-1169.
38. Palaniyappan L, Insole L, Ferrier N (2009). Combining antidepressants: a review of evidence. APT 15: 90-99.
39. Palucha A, Branski P, Szewczyk B, Wieronska J, Klak K, Pilc A (2005). Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist. Pharmacol Biochem Behav 81: 901-906.
40. Pilc A, Chaki S, Nowak G, Witkin JM (2008). Mood disorders: regulation by metabotropic glutamate receptors. Biochem Pharmacol 75: 997-1006.
41. Popoli M, Yan Z, McEwen BS, Sanacora G (2012). The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission. Nat Rev Neurosci 13: 22-37.
42. Prins J, Olivier B, Korte SM (2011). Triple reuptake inhibitors for treating subtypes of major depressive disorder: the monoamine hypothesis revisited. Expert Opin Investig Drugs 20: 1107-1130.
43. Rietschel M, Mattheisen M, Frank J, Treutlein J, Degenhardt F, Breuer R et al (2010). Genome-wide association-, replication-, and neuroimaging study implicates HOMER1 in the etiology of major depression. Biol Psychiatry 68 : 578-585.
44. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D et al (2006). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR∗D report. Am J Psychiatry 163: 1905-1917.
45. Sagvolden T, Russell VA, Aase H, Johansen EB, Farshbaf M (2005). Rodent models of attention-deficit/hyperactivity disorder. Biol Psychiatry 57: 1239-1247.
46. Sanacora G, Treccani G, Popoli M (2012). Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 62: 63-77.
47. Savignac HM, Finger BC, Pizzo RC, O'Leary OF, Dinan TG, Cryan JF (2011). Increased sensitivity to the effects of chronic social defeat stress in an innately anxious mouse strain. Neuroscience 192: 524-536.
48. Scharf SH, Sterlemann V, Liebl C, Müller MB, Schmidt MV (2013). Chronic social stress during adolescence: interplay of paroxetine treatment and ageing. Neuropharmacology 72C: 38-46.
49. Schmidt MV, Sterlemann V, Ganea K, Liebl C, Alam S, Harbich D et al (2007). Persistent neuroendocrine and behavioral effects of a novel, etiologically relevant mouse paradigm for chronic social stress during adolescence. Psychoneuroendocrinology 32: 417-429.
50. Schmidt MV, Trümbach D, Weber P, Wagner K, Scharf SH, Liebl C et al (2010). Individual stress vulnerability is predicted by shortterm memory and AMPA receptor subunit ratio in the hippocampus. J Neurosci 30: 16949-16958.
51. Shiraishi-Yamaguchi Y, Furuichi T (2007). The Homer family proteins. Genome Biol 8: 206.
52. Szumlinski KK, Lominac KD, Kleschen MJ, Oleson EB, Dehoff MH, Schwarz MK et al (2005). Behavioral and neurochemical phenotyping of Homer1 mutant mice: possible relevance to schizophrenia. Genes Brain Behav 4: 273-288.
53. Szumlinski KK, Dehoff MH, Kang SH, Frys KA, Lominac KD, Klugmann M et al (2004). Homer proteins regulate sensitivity to cocaine. Neuron 43: 401-413.
54. Thase ME (2006). Preventing relapse and recurrence of depression: a brief review of therapeutic options. CNS Spectr 11: 12-21.
55. Tronson NC, Guzman YF, Guedea AL, Huh KH, Gao C, Schwarz MK et al (2010). Metabotropic glutamate receptor 5/Homer interactions underlie stress effects on fear. Biol Psychiatry 68: 1007-1015.
56. Tu JC, Xiao B, Naisbitt S, Yuan JP, Petralia RS, Brakeman P et al (1999). Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins. Neuron 23: 583-592.
57. Tu JC, Xiao B, Yuan JP, Lanahan AA, Leoffert K, Li M et al (1998). Homer binds a novel proline-rich motif and links group 1 metabotropic glutamate receptors with IP3 receptors. Neuron 21: 717-726.
58. Wagner KV, Hartmann J, Mangold K, Wang XD, Labermaier C, Liebl C et al (2013). Homer1 mediates acute stress-induced cognitive deficits in the dorsal hippocampus. J Neurosci 33: 3857-3864.
59. Wagner KV, Marinescu D, Hartmann J, Wang XD, Labermaier C, Scharf SH et al (2012). Differences in FKBP51 regulation following chronic social defeat stress correlate with individual stress sensitivity: influence of paroxetine treatment. Neuropsychopharmacology 37: 2797-2808.
60. Wagner KV, Wang XD, Liebl C, Scharf SH, Müller MB, Schmidt MV (2011). Pituitary glucocorticoid receptor deletion reduces vulnerability to chronic stress. Psychoneuroendocrinology 36: 579-587.
61. Wang XD, Chen Y, Wolf M, Wagner KV, Liebl C, Scharf SH et al (2011). Forebrain CRHR1 deficiency attenuates chronic stress-induced cognitive deficits and dendritic remodeling. Neurobiol Dis 42: 300-310.
62. Webhofer C, Gormanns P, Reckow S, Lebar M, Maccarrone G, Ludwig T et al (2013). Proteomic and metabolomic profiling reveals time-dependent changes in hippocampal metabolism upon paroxetine treatment and biomarker candidates. J Psychiatr Res 47: 289-298.
63. Yim YS, Lee J, Kim GT, Song T, Kim CH, Kim DG (2012). Hippocampal mGluR5 predicts an occurrence of helplessness behavior after repetitive exposure to uncontrollable stress. Neurosci Lett 519: 62-66.
64. Yuan JP, Kiselyov K, Shin DM, Chen J, Shcheynikov N, Kang SH et al (2003). Homer binds TRPC family channels and is required for gating of TRPC1 by IP3 receptors. Cell 114: 777-789.